Attendee Breakdown

This summit is designed for the leaders advancing neuropsychiatric drug development. Connect with peers across biotech, pharma, academia, and clinical practice to exchange insights, share experiences, and forge the partnerships that drive innovation and deliver meaningful progress for patients.

Explore the full breakdown and see who's in the room.

Companies in Attendance

University of Colorado Anschutz Medical Campus • Neurocrine Biosciences • Alkermes • Supernus Pharmaceuticals • PsychoGenics Inc • Brown University • Otsuka America Pharmaceutical • Neurosterix • University of Wyoming • AbbVie • Broad Institute • Psilera Bioscience • NYC Health + Hospitals Kings County Hospital Center • Uprise Health • Pangea Botanica • Cleveland Clinic Taussig Cancer Institute • Illumind Therapeutics • Murck Neuroscience • Delix Therapeutics • COMPASS Pathways • Seaport Therapeutics • Otsuka • Stifel Nicolaus • H. Lundbeck • Cowen and Company • Vida Ventures • Novo A/S • Kynexis Therapeutics • Helus Pharma • Harvard Medical School • Monument Therapeutics • Beacon • Neumora Therapeutics • General Atlantic • Boehringer Ingelheim • Gilgamesh Pharmaceuticals • University of Maryland • Xylo Bio • Karuna Therapeutics • Washington University School of Medicine in St. Louis • University of Connecticut • Spinogenix • United States Food and Drug Administration • Foundation for the National Institutes of Health • Bristol Myers Squibb • Cardiovascular Genetics • Broad Institute of Massachusetts Institute of Technology and Harvard • Eli Lilly and Company • Transpharmation • Sama Therapeutics • Ulysses Neuroscience

Job Titles Represented

Associate Director • Associate Scientific Director • Assistant Professor of Psychiatry • Distinguished Professor and Director • Chief Executive Officer • Chief Medical Officer • Chief Operating Officer • Chief Patient Officer • Chief Scientific Officer • Co‑Founder • Director • Director, Neuroscience • Global Head of Regulatory Affairs • Group Leader and Research Scientist • Head of Clinical Development • Head of Preclinical Neuropharmacology • Head of Translational Science • Head of Research and Development • Managing Director • Postdoctoral Research Associate • Principal Investigator • Principal Scientist • Professor • Professor and Founder • Research Scientist • Researcher • Science Advisor • Scientific Director • Scientist • Senior Director • Senior Medical Director • Senior Scientist • Senior Vice President • Venture Capital Professional • Vice President

69647 - attendee breakdown

Explore the Full Event Guide

  • 46+ World Class Speakers with Cutting Edge Insights
  • 10+ Hours of Face-to-Face Networking Opportunities
  • 3 Days of Unmissable Data-Driven Content
  • 2 Dedicated Tracks of Content Spanning Discovery to Access for the Whole Team
69647 - 9th Neuropsychiatric Drug Development Summit 2026